End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.53 CNY | +3.29% | -2.21% | -19.55% |
Apr. 17 | Hisun Pharma's Unit Gets Nod for Pig Vaccine | MT |
Apr. 02 | Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023. | CI |
Sales 2023 * | 12.65B 1.75B | Sales 2024 * | 13.27B 1.83B | Capitalization | 8.84B 1.22B |
---|---|---|---|---|---|
Net income 2023 * | 605M 83.6M | Net income 2024 * | 648M 89.54M | EV / Sales 2023 * | 1.05 x |
Net Debt 2023 * | 4.42B 610M | Net Debt 2024 * | 3.53B 487M | EV / Sales 2024 * | 0.93 x |
P/E ratio 2023 * |
15.4
x | P/E ratio 2024 * |
14.2
x | Employees | 8,325 |
Yield 2023 * |
0.8% | Yield 2024 * |
0.93% | Free-Float | 53.86% |
1 day | +3.29% | ||
1 week | -2.21% | ||
Current month | -2.08% | ||
1 month | -5.52% | ||
3 months | -15.01% | ||
6 months | -32.28% | ||
Current year | -19.55% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Qing Yang
CEO | Chief Executive Officer | - | 23-08-30 |
Jia Qiu Du
CHM | Chairman | 50 | 19-05-12 |
Wei Hong Xiao
PSD | President | 56 | 23-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shun Bing Yu
CHM | Chairman | 61 | - |
Jia Yi Zhao
BRD | Director/Board Member | 64 | 19-05-12 |
Li Rong Yang
BRD | Director/Board Member | 62 | 19-05-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 7.53 | +3.29% | 9,629,597 |
24-04-16 | 7.29 | -2.54% | 10,950,740 |
24-04-15 | 7.48 | -1.58% | 10,972,380 |
24-04-12 | 7.6 | -0.78% | 7,730,428 |
24-04-11 | 7.66 | -0.52% | 5,992,170 |
End-of-day quote Shanghai S.E., April 16, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.55% | 1.24B | |
+28.79% | 676B | |
+23.89% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+2.89% | 210B | |
-0.32% | 204B | |
-9.86% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- 600267 Stock